Obstetrics & Gynecology Doctors in New City, NY Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Dr. Rocio D Villeda Gonzalez, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 E Eckerson Rd Ste 160, New City, NY 10956 Phone: 845-634-8400

Dr. Joseph Maselli, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 510 Route 304, New City, NY 10956 Phone: 845-634-8400    Fax: 845-634-0979

Dr. Irene Kelly, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 510 Route 304, New City, NY 10956 Phone: 845-634-8400    Fax: 845-634-0979

Dr. Jae-hak Choe, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 200 E Eckerson Rd, 2-9, New City, NY 10956 Phone: 845-425-1020    Fax: 845-426-3911

Dr. Marie Sabatini, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 510 Route 304, New City, NY 10956 Phone: 845-634-8400    Fax: 845-634-0979

Dr. Sharon Quayle, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 510 Route 304, New City, NY 10956 Phone: 845-634-8400    Fax: 845-634-0979

News Archive

Luminex launches FDA-cleared xTAG Cystic Fibrosis 60 Kit v2 diagnostic test

Luminex Corporation, the worldwide leader in multiplexed solutions, today announced the full commercial launch of its xTAG Cystic Fibrosis 60 Kit v2, a new diagnostic test that can simultaneously screen a single blood sample for up to 60 cystic fibrosis-causing genetic mutations in a matter of hours.

World Cancer Declaration sets ambitious targets for 2020

A summit of more than 60 high-level policymakers, leaders and health experts have adopted a global plan aimed at tackling the growing cancer crisis in developing countries.

Amgen starts Phase 3 study assessing the benefit of Kyprolis in patients with relapsed/refractory multiple myeloma

Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).

Karolinska Institutet professor receives Fernström Foundation Nordic Prize for obesity research

This year's Fernström Foundation Nordic Prize, worth SEK 1 million, goes to Professor Peter Arner from Karolinska Institutet, Sweden, who conducts research on fat. His team was the first to show that fat cells are formed throughout one's lifetime, not just in childhood.

Cord Blood America answers shareholder questions about its new laboratory in Las Vegas

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, today addressed shareholder questions about its new laboratory in Las Vegas, and its recently refiled S1 with the SEC, in an interview of Matthew Schissler, founder and CEO, by analyst Francis Gaskins.

Read more Medical News

› Verified 8 days ago